Assessing medication effects in the MTA study using neuropsychological outcomes - Wikidata - wikimedia - TriplyDB

Assessing medication effects in the MTA study using neuropsychological outcomes

Assessing medication effects in the MTA study using neuropsychological outcomes

http://www.wikidata.org/entity/Q58822768

about

Treatment of Aggressive ADHD in Children and Adolescents: Conceptualization and Treatment of Comorbid Behavior Disorders Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.The restless brain: attention-deficit hyperactivity disorder, resting-state functional connectivity, and intrasubject variability.Interstimulus jitter facilitates response control in children with ADHD.Detrimental effects of acute nicotine on the response-withholding performance of spontaneously hypertensive and Wistar Kyoto rats Intra-individual variability among children with ADHD on a working memory task: an ex-Gaussian approach Reliability concerns in the repeated computerized assessment of attention in children.Examining predictors of reaction times in children with ADHD and normal controls.Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD.Reinforcement enhances vigilance among children with ADHD: comparisons to typically developing children and to the effects of methylphenidate.Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.Relation between outcomes on a continuous performance test and ADHD symptoms over time.Reaction time variability in children with ADHD symptoms and/or dyslexia.Reaction time variability in ADHD: a review Do attention deficits influence IQ assessment in children and adolescents with ADHD?Psychological interpretation of the ex-Gaussian and shifted Wald parameters: a diffusion model analysis.Improving outcomes for youth with ADHD: a conceptual framework for combined neurocognitive and skill-based treatment approaches.A preliminary study of the effects of working memory training on brain function Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD.Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.Sleep, attention, and executive functioning in children with attention-deficit/hyperactivity disorder.Attachment as a component of attention-deficit hyperactivity disorder.Time-on-task in children with ADHD: an ex-Gaussian analysis.The impact of a multimodal Summer Camp Training on neuropsychological functioning in children and adolescents with ADHD: an exploratory study.Visual memory as a potential cognitive endophenotype of attention deficit hyperactivity disorder.Methylphenidate effects on neural activity during response inhibition in healthy humans.Neuropsychological functions among adolescents with persistent, subsyndromal and remitted attention deficit hyperactivity disorder.Methylphenidate in children with ADHD with or without learning disability.Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?Does stimulant pretreatment modify atomoxetine effects on core symptoms of ADHD in children assessed by quantitative measurement technology?Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial.D-amphetamine improves attention performance in adolescent Wistar, but not in SHR rats, in a two-choice visual discrimination task.Do ADHD Children With and Without Child Behavior Checklist–Dysregulation Profile Have Different Clinical Characteristics, Cognitive Features, and Treatment Outcomes?

P2860

Q22241212-92EE6D2C-9D8A-4C51-9AD7-4F475F50B91B Q27687469-1E0C7591-925D-49BC-AF03-8E8777D524D0 Q33511059-C6167929-7485-4C61-AC6F-95FF1FFB86C3 Q33684391-E867FCC6-6DDE-43B2-AA4A-62FD861CB2AF Q33693605-3045ACD7-6689-44BC-92DC-628E9423969D Q33938720-AE26A84B-A2AD-4420-996E-D47FC51A5BA9 Q33973361-B87C3B19-9162-44DC-8257-1C92ADD0003E Q34632432-4BF5CBF9-2C65-4914-9800-917045C4E0B5 Q34661181-9B9D2C89-2BDF-47A1-9B7C-4BC982F80687 Q34687232-95F7D057-B5E8-45C8-9126-01508D7DFDEC Q34725704-3C89BD5B-1A7C-41F2-B2A7-BE7DC79BD3EA Q34744662-4E6D4529-0E36-4798-A486-28EA4A3395E1 Q35038149-10C0E89A-6931-42E0-8841-370C023D215C Q36147539-91B3EC8E-732E-4C3E-9397-A9EDA618BCE9 Q36233143-5A856D9C-AE7C-4B5D-B1D5-630D3EC9FDBD Q37278818-C4CC7ABC-56C3-4254-A9CB-6ED2DE38A386 Q37611330-3EBF63B3-DFED-44F3-84F9-90F1912EA1DE Q38239628-1E337658-83C3-4284-AC90-A8DEBDAD35AD Q41370468-1CAD4E80-39D8-42E0-BBA1-E7436A78E000 Q42597685-6ED8CEC2-4976-471C-8745-8D333395FB50 Q42912275-211DB95A-E924-413F-9081-CCB02BC3CD84 Q43180467-A6818133-8E5F-4DA2-BBBA-7651B6E29416 Q43776196-21257CC2-774C-4A26-8A04-A14D4053E8BB Q43972981-FA415C93-A4A7-42EF-B678-39ED9C533782 Q44032125-3FD7260D-AB1D-467C-AAF9-994DE6063D09 Q44070945-3215FF93-964B-40EC-8A25-0A04F5FDBC46 Q44778054-1E0493E9-6C67-47A1-8FB4-B7FC01DC0AF0 Q44793419-66E5F5FF-992D-4CCF-B4D8-327A8417E647 Q45777837-092623D0-23F1-460E-B61F-17ADAE0C5501 Q46024625-4138FE14-1BE7-469A-98B3-78AF7FCBA4AF Q47209988-5F1E3637-9B89-4C7C-9636-52ADBDFF9AD5 Q47727272-5E6177EC-B8CC-447D-ABB8-897014AE4DC5 Q48883847-380E57D9-145B-41AC-A1DC-BEECDD25D3D0 Q53480200-6C5F74F6-01B3-4CAC-9282-CA7E9FF5CA01 Q58810797-9BD98E9D-793B-44BF-9AD2-F91240DFA44D

P2860

Assessing medication effects in the MTA study using neuropsychological outcomes

http://www.wikidata.org/entity/Q58822768

description

article

@en

im Mai 2006 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2006

@uk

name

Assessing medication effects in the MTA study using neuropsychological outcomes

@en

Assessing medication effects in the MTA study using neuropsychological outcomes

@nl

type

label

Assessing medication effects in the MTA study using neuropsychological outcomes

@en

Assessing medication effects in the MTA study using neuropsychological outcomes

@nl

prefLabel

Assessing medication effects in the MTA study using neuropsychological outcomes

@en

Assessing medication effects in the MTA study using neuropsychological outcomes

@nl

P1433

Q58822768-8018DBB7-FBA6-453A-9236-DF04EED43C3B

P1476

Q58822768-2F949B5C-C384-4601-9C95-23DF0D70496A

P2093

Q58822768-07938318-A666-495D-86F6-0C12396C984C

Q58822768-3D7962C1-BA3C-4CDA-9304-0537102C9322

Q58822768-5AB77EE7-0ED2-47A9-9C5C-0F06CEF0233C

Q58822768-5AC16295-A370-4B68-A839-86E082ACAAF3

Q58822768-7DB7600A-08B0-46D6-8860-47C5AEA1A8FB

Q58822768-88D0C3F6-F806-4E56-9277-948FDFF8730C

Q58822768-897AC53F-6AED-4D98-BAD2-EDEC67071BBD

Q58822768-89C74240-3674-441A-97BA-E484B87CF1F5

Q58822768-8E0408B1-4B5C-4591-88BB-522EA492E0F9

Q58822768-922280FE-5AA0-4C73-8068-7D8C6DA6ABE2

P2860

Q58822768-07EEF98B-4E26-4D98-AA7B-443B2D398819

Q58822768-304FBB9D-6652-4EC0-A1CC-F46763F0231E

Q58822768-3FA1E5DD-94C1-4552-902E-6C53C34B191A

Q58822768-63C5D765-E393-4709-B8CD-8104224F2F39

Q58822768-70592D7D-C8B2-40FC-AA74-495AF59782E6

Q58822768-8AC8092B-959F-49A7-85AA-A39BA247756A

Q58822768-98E632B2-D5E9-4903-866B-FABF8FF5590F

Q58822768-A1DCE970-83BF-42FC-88EE-6998F90DD97B

Q58822768-C756012F-D63A-4121-B197-185CC3A27D69

Q58822768-DD1A858D-A8C6-4CD9-90E8-2F36EC46A00A

P304

Q58822768-667EFC3C-BDF0-4D52-AD41-19F37C9323BA

P31

Q58822768-D1B5E0CE-DF0A-4838-9E45-EF5B76BF7DF0

P356

Q58822768-913672B6-F4D3-4866-9AE6-6E5B2F1A2A2E

P433

Q58822768-938A9125-410F-4B20-8320-E173044849CC

P478

Q58822768-92BF1ADF-0019-4D80-BC75-AC4619504AA5

P50

Q58822768-3044CE44-B6BD-415C-A5F7-E79265987C3C

Q58822768-D43816E1-C27B-4650-976C-5AC54DC1C679

P577

Q58822768-86EEC4DE-0300-4994-B958-358379CA0F19

P698

Q58822768-8AF9A0F8-9A63-47DC-A4DD-F684DA172998

P921

Q58822768-538D9DC0-B8A3-4685-95AC-9345AB84F9A8

P356

J.1469-7610.2005.01469.X

P1433

The Journal of Child Psychology and Psychiatry

P1476

Assessing medication effects in the MTA study using neuropsychological outcomes

@en

P2093

Aaron S Hervey

http://www.w3.org/2001/XMLSchema#string

Benedetto Vitiello

http://www.w3.org/2001/XMLSchema#string

Betsy Hoza

http://www.w3.org/2001/XMLSchema#string

C Keith Conners

http://www.w3.org/2001/XMLSchema#string

Glen Elliott

http://www.w3.org/2001/XMLSchema#string

Howard B Abikoff

http://www.w3.org/2001/XMLSchema#string

James M Swanson

http://www.w3.org/2001/XMLSchema#string

Jeffery N Epstein

http://www.w3.org/2001/XMLSchema#string

Joanne B Severe

http://www.w3.org/2001/XMLSchema#string

John S March

http://www.w3.org/2001/XMLSchema#string

P2860

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses

The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.

The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics.

Continuous performance test performance in a normative epidemiological sample.

National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder.

Relations between Continuous Performance Test performance measures and ADHD behaviors.

Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety.

Mean response times, variability, and skew in the responding of ADHD children: a response time distributional approach.

Behavioral characteristics of DSM-IV ADHD subtypes in a school-based population.

National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.

P304

446-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1469-7610.2005.01469.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Peter S. Jensen

Jeffrey Newcorn

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16671928

http://www.w3.org/2001/XMLSchema#string

P921

neuropsychology